<VariationArchive RecordType="classified" VariationID="212188" VariationName="NM_006517.5(SLC16A2):c.1392dup (p.Ile465fs)" VariationType="Duplication" Accession="VCV000212188" Version="6" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-04-09" DateCreated="2015-10-05" MostRecentSubmission="2015-10-05">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="209181" VariationID="212188">
      <GeneList>
        <Gene Symbol="SLC16A2" FullName="solute carrier family 16 member 2" GeneID="6567" HGNC_ID="HGNC:10923" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="74421493" stop="74533916" display_start="74421493" display_stop="74533916" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="73641327" stop="73753763" display_start="73641327" display_stop="73753763" Strand="+" />
          </Location>
          <OMIM>300095</OMIM>
          <Haploinsufficiency last_evaluated="2012-06-28" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC16A2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-06-28" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC16A2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_006517.5(SLC16A2):c.1392dup (p.Ile465fs)</Name>
      <CanonicalSPDI>NC_000023.11:74529428:CCCCCC:CCCCCCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>Xq13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="74529428" stop="74529429" display_start="74529428" display_stop="74529429" variantLength="1" positionVCF="74529428" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="73749263" stop="73749264" display_start="73749263" display_stop="73749264" variantLength="1" positionVCF="73749263" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
      </Location>
      <ProteinChange>I465fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.73749269dup" Assembly="GRCh37">
            <Expression>NC_000023.10:g.73749269dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.74529434dup" Assembly="GRCh38">
            <Expression>NC_000023.11:g.74529434dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011641.2" sequenceAccession="NG_011641" sequenceVersion="2" change="g.113185dup">
            <Expression>NG_011641.2:g.113185dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006517.5" sequenceAccession="NM_006517" sequenceVersion="5" change="c.1392dup" MANESelect="true">
            <Expression>NM_006517.5:c.1392dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_006508.2" sequenceAccession="NP_006508" sequenceVersion="2" change="p.Ile465fs">
            <Expression>NP_006508.2:p.Ile465fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA277043" DB="ClinGen" />
        <XRef Type="rs" ID="797045962" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_006517.5(SLC16A2):c.1392dup (p.Ile465fs) AND Allan-Herndon-Dudley syndrome" Accession="RCV000192887" Version="6">
        <ClassifiedConditionList TraitSetID="3177">
          <ClassifiedCondition DB="MedGen" ID="C0795889">Allan-Herndon-Dudley syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2013-02-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2013-02-08" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2015-10-05" MostRecentSubmission="2015-10-05">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="3177" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="148" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">T3 RESISTANCE</ElementValue>
                <XRef Type="MIM" ID="300523" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">TRIIODOTHYRONINE RESISTANCE</ElementValue>
                <XRef Type="MIM" ID="300523" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Allan-Herndon-Dudley syndrome</ElementValue>
                <XRef ID="Allan-Herndon-Dudley+Syndrome/306" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010354" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MCT8-Specific Thyroid Hormone Cell-Membrane Transporter Deficiency</ElementValue>
                <XRef ID="NBK26373" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MCT8 (SLC16A2)-Specific Thyroid Hormone Cell Transporter Deficiency</ElementValue>
                <XRef ID="NBK26373" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Allan-Herndon syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Monocarboxylate transporter-8 deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Triiodothyronine resistence</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">T3 resisitence</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-linked mental retardation with hypotonia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mental retardation and muscular atrophy</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">AHDS</ElementValue>
                <XRef Type="MIM" ID="300523" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5617" />
                <XRef ID="5617" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Allan-Herndon-Dudley syndrome (AHDS), an X-linked disorder, is characterized in males by neurologic findings (hypotonia and feeding difficulties in infancy, developmental delayÂ / intellectual disability ranging from mild to profound) and later-onset pyramidal signs, extrapyramidal findings (dystonia, choreoathetosis, paroxysmal movement disorder, hypokinesia, masked facies), and seizures, often with drug resistance. Additional findings can include dysthyroidism (manifest as poor weight gain, reduced muscle mass, and variable cold intolerance, sweating, elevated heart rate, and irritability) and pathognomonic thyroid test results. Most heterozygous females are not clinically affected but may have minor thyroid test abnormalities.</Attribute>
                <XRef ID="NBK26373" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301789</ID>
                <ID Source="BookShelf">NBK26373</ID>
              </Citation>
              <XRef ID="59" DB="Orphanet" />
              <XRef ID="C0795889" DB="MedGen" />
              <XRef ID="MONDO:0010354" DB="MONDO" />
              <XRef Type="MIM" ID="300523" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="460529" SubmissionDate="2015-09-15" DateLastUpdated="2015-10-05" DateCreated="2015-10-05">
        <ClinVarSubmissionID localKey="NM_006517.3(SLC16A2):c.1614dup|Allan-Herndon-Dudley syndrome" />
        <ClinVarAccession Accession="SCV000248891" DateUpdated="2015-10-05" DateCreated="2015-10-05" Type="SCV" Version="1" SubmitterName="Genetic Services Laboratory, University of Chicago" OrgID="1238" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2013-02-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2007</Attribute>
          <Citation>
            <ID Source="PubMed">18414213</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC16A2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006517.3:c.1614dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Allan-Herndon-Dudley syndrome</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="460529" TraitType="Disease" MappingType="Name" MappingValue="Allan-Herndon-Dudley syndrome" MappingRef="Preferred">
        <MedGen CUI="C0795889" Name="Allan-Herndon-Dudley syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

